ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
GSK2374697, a long duration glucagon-like peptide-1 (GLP-1) receptor agonist, reduces postprandial circulating endogenous total GLP-1 and peptide YY in healthy subjects
Diabetes Obesity and Metabolism
◽
10.1111/dom.12533
◽
2015
◽
Vol 17
(10)
◽
pp. 1007-1010
◽
Cited By ~ 8
Author(s):
J. Lin
◽
R. J. Hodge
◽
R. L. O'Connor-Semmes
◽
D. J. Nunez
Keyword(s):
Healthy Subjects
◽
Receptor Agonist
◽
Peptide Yy
◽
Long Duration
◽
Glucagon Like Peptide
◽
Glucagon Like Peptide 1
Download Full-text
Related Documents
Cited By
References
The glucagon-like peptide-1 (GLP-1) receptor agonist, exenatide, inhibits small intestinal motility, flow, transit and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomised controlled trial.
Diabetes
◽
10.2337/db15-0893
◽
2015
◽
pp. db150893
◽
Cited By ~ 7
Author(s):
Sony S. Thazhath
◽
Chinmay S. Marathe
◽
Tongzhi Wu
◽
Jessica Chang
◽
Joan Khoo
◽
...
Keyword(s):
Type 2 Diabetes
◽
Healthy Subjects
◽
Receptor Agonist
◽
Controlled Trial
◽
Small Intestinal Motility
◽
Glucagon Like Peptide
◽
Small Intestinal
◽
Glucagon Like Peptide 1
◽
Randomised Controlled
Download Full-text
Population Pharmacokinetics of Lixisenatide, a Once- Daily Human Glucagon-Like Peptide-1 Receptor Agonist, in Healthy Subjects and in Patients with Type 2 Diabetes
Journal of Pharmaceutics & Drug Delivery Research
◽
10.4172/2325-9604.1000112
◽
2013
◽
Vol 02
(01)
◽
Cited By ~ 3
Keyword(s):
Type 2 Diabetes
◽
Population Pharmacokinetics
◽
Healthy Subjects
◽
Receptor Agonist
◽
Once Daily
◽
Glucagon Like Peptide
◽
Glucagon Like Peptide 1
Download Full-text
Dulaglutide, a glucagon-like peptide-1 receptor agonist: in the search for survival molecule
Endocrinology: News, Opinions, Training
◽
10.33029/2304-9529-2020-9-2-49-58
◽
2020
◽
Vol 9
(2)
◽
pp. 49-58
Author(s):
A.S. Ametov
◽
◽
A.O. Nevolnikova
◽
E.A. Tertychnaya
◽
O.A. Mishra
◽
...
Keyword(s):
Receptor Agonist
◽
Glucagon Like Peptide
◽
Glucagon Like Peptide 1
Download Full-text
Liraglutide, a glucagon-like peptide-1 receptor agonist, improves bone mass and architecture in ovariectomised mice
Endocrine Abstracts
◽
10.1530/endoabs.34.p8
◽
2014
◽
Author(s):
Marie Pereira
◽
Jeshmi Jeyabalan
◽
Camilla Sofie Jorgensen
◽
Mark Cleasby
◽
Mark Hopkinson
◽
...
Keyword(s):
Bone Mass
◽
Receptor Agonist
◽
Glucagon Like Peptide
◽
Glucagon Like Peptide 1
Download Full-text
Patients with obesity caused by melanocortin-4 receptor mutations can be treated with a glucagon-like peptide-1 receptor agonist
Yearbook of Paediatric Endocrinology
◽
10.1530/ey.16.11.12
◽
2019
◽
Author(s):
Iepsen EW
◽
Zhang J
◽
Thomsen HS
◽
Hansen EL
◽
Hollensted M
◽
...
Keyword(s):
Receptor Agonist
◽
Melanocortin 4 Receptor
◽
Glucagon Like Peptide
◽
Glucagon Like Peptide 1
Download Full-text
Use of Big-Data Algorithms to Characterize Patients with T2D on Basal Insulin (BI) Who Add a Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) and Predict Their A1C Response
Diabetes
◽
10.2337/db18-100-lb
◽
2018
◽
Vol 67
(Supplement 1)
◽
pp. 100-LB
◽
Cited By ~ 1
Author(s):
ESTHER ZIMMERMANN
◽
ADAM LENART
◽
JOAO DIOGO DA ROCHA FERNANDES
◽
SARAH EGGERT
◽
MATTIS F. RANTHE
Keyword(s):
Big Data
◽
Basal Insulin
◽
Receptor Agonist
◽
Glucagon Like Peptide
◽
Glucagon Like Peptide 1
Download Full-text
Combination of Premixed Insulin with Glucagon-Like Peptide-1 Receptor Agonist (GLP-1) for Uncontrolled Type 2 Diabetes Mellitus (T2DM) Patients
Diabetes
◽
10.2337/db18-2231-pub
◽
2018
◽
Vol 67
(Supplement 1)
◽
pp. 2231-PUB
Author(s):
SASAN FAZELI
◽
NICOLE EHRHARDT
Keyword(s):
Diabetes Mellitus
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Receptor Agonist
◽
Premixed Insulin
◽
Glucagon Like Peptide
◽
Glucagon Like Peptide 1
Download Full-text
Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Attenuates Prostate Cancer Cell Proliferation via Phosphorylation of MKP-1
Diabetes
◽
10.2337/db18-1957-p
◽
2018
◽
Vol 67
(Supplement 1)
◽
pp. 1957-P
Author(s):
TAKAKO KAWANAMI
◽
TAKASHI NOMIYAMA
◽
YURIKO HAMAGUCHI
◽
TOMOKO TANAKA
◽
TOSHIHIKO YANASE
Keyword(s):
Prostate Cancer
◽
Cell Proliferation
◽
Cancer Cell
◽
Receptor Agonist
◽
Prostate Cancer Cell
◽
Cancer Cell Proliferation
◽
Glucagon Like Peptide
◽
Glucagon Like Peptide 1
Download Full-text
938-P: The Relationship between Timing of Initiation on a Glucagon-Like Peptide-1 Receptor Agonist and HbA1c among Patients with Type 2 Diabetes
Diabetes
◽
10.2337/db20-938-p
◽
2020
◽
Vol 69
(Supplement 1)
◽
pp. 938-P
Author(s):
RALEIGH E. MALIK
◽
REEMA MODY
◽
MAUREEN J. LAGE
◽
KRISTINA BOYE
Keyword(s):
Type 2 Diabetes
◽
Receptor Agonist
◽
Glucagon Like Peptide
◽
Glucagon Like Peptide 1
◽
Timing Of Initiation
◽
The Relationship
Download Full-text
2106-P: Glucagon-Like Peptide-1 Receptor Agonist Exenatide Promotes ß-Cell Function via Activation of PPARd/UCP-2 Pathway
Diabetes
◽
10.2337/db20-2106-p
◽
2020
◽
Vol 69
(Supplement 1)
◽
pp. 2106-P
Author(s):
YANNA SU
◽
WEN XU
◽
BEISI LIN
◽
ZIYU LIU
◽
YALAN CHEN
◽
...
Keyword(s):
Receptor Agonist
◽
Cell Function
◽
Glucagon Like Peptide
◽
Glucagon Like Peptide 1
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close